Related Experiment Video
Updated: Aug 3, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Cardiac protection as priority strategy of cardiovascular prevention in high blood pressure]
V Barrios Alonso1, A Calderón Montero, C Escobar Cervantes
1Instituto de Cardiología, Hospital Ramón y Cajal, Madrid. vbarrios.hrc@salud.madrid.org
Insights
Cardiac complications remain a major cause of death and illness from high blood pressure (HBP). Protecting the heart is a priority for managing HBP and preventing serious health issues.
Area of Science:
- Cardiology
- Hypertension Research
- Public Health
Context:
- Cardiac complications are the leading cause of morbidity and mortality associated with high blood pressure (HBP).
- Despite decreased incidence of cerebrovascular accidents (ACVA), cardiac complications persist due to multifactorial origins.
- Left ventricular hypertrophy is a key factor in hypertensive heart disease, encompassing heart failure, ischemic heart disease, arrhythmias, and sudden death.
Purpose:
- To highlight the significant burden of cardiac complications in high blood pressure (HBP) management.
- To emphasize the persistent challenge of cardiac issues despite advances in stroke prevention.
- To underscore the critical role of cardiac protection in addressing HBP-related morbidity and mortality.
Summary:
- High blood pressure (HBP) significantly contributes to cardiac morbidity and mortality.
- Left ventricular hypertrophy is central to hypertensive heart disease, leading to various cardiac conditions.
- Cardiac complications, including heart failure and arrhythmias, represent a major health concern in HBP patients.
Impact:
- Cardiac protection strategies are crucial for improving outcomes in high blood pressure (HBP) patients.
- Addressing cardiac complications is essential for reducing the overall burden of HBP.
- Prioritizing cardiac health in HBP management can mitigate severe human and socio-economic consequences.
Abstract:
Cardiac complications are the main cause of morbidity and mortality related with HBP in our setting and entail first magnitude human and social-health care consequences. Although the incidence of ACVA has decreased in recent decades, this has not occurred with the same intensity for cardiac complications, probably due to their multifactorial origin. Left ventricular hypertrophy, main etiologic responsible factor of hypertensive heart disease that includes heart failure, ischemic heart disease, arrhythmias and sudden death are found as nuclear element of the cardiac disease. Consequently, the magnitude, etiological diversity, vulnerability and social-health care implications grant the intervention on cardiac protection a priority role in the management of HBP and its complications.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Coronary Artery Disease IV: Preventive Measures
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy V: Interprofessional Care
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management

